Resilience-Building Interventions for Early Life Adversity
(CARE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how resilience-building interventions can improve behavior, psychosocial health, and biological responses in young children who have faced early life challenges. It tests two treatments: a Caregiver-Child Intervention, focusing on various settings and delivery methods, and Enhanced Primary Care, which supports families in connecting with social resources. Families with young children (aged 2 to 5) who have faced adversity and can access digital devices for potential telehealth sessions might be a good fit. As an unphased trial, this study offers families the chance to contribute to innovative research that could enhance support systems for young children facing adversity.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you or your child have significant medical conditions requiring treatments like immunomodulators, chemotherapy, or hormonal therapy, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the Caregiver-Child Intervention addresses early life challenges. In studies, caregivers noted that children often encountered many difficult experiences. Although these experiences can be challenging, the intervention aims to help both caregivers and children build resilience. Importantly, studies found no evidence of harm or negative effects from the intervention.
For the Enhanced Primary Care approach, which assists families in finding social support services, specific safety data is unavailable. However, because it helps families access resources, it is likely to be well-received. Generally, services that support families in this way are considered safe and helpful.
In summary, both interventions focus on providing support and building resilience. They are expected to be safe, with no known risks reported in the research.12345Why are researchers excited about this trial?
Researchers are excited about these interventions for early life adversity because they offer new ways to support both caregivers and children. The Caregiver-Child Intervention is unique because it explores different settings, like home versus clinic, and delivery methods, such as one-on-one or group sessions, to see how these factors affect outcomes. This multifaceted approach could lead to more tailored and effective support strategies. On the other hand, Enhanced Primary Care focuses on connecting families with social resources, which can address underlying social needs that often accompany early life adversity. These innovative interventions could provide more comprehensive and adaptable support than standard care options.
What evidence suggests that this trial's treatments could be effective for early life adversity?
Research shows that programs involving both caregivers and children can significantly enhance children's resilience when facing early life challenges. In this trial, participants may receive the Caregiver-Child Intervention, which helps caregivers respond more effectively to their children's needs, resulting in improved social and behavioral outcomes for the children. For example, the "Supporting Early Learning Study" found that such programs benefited both caregivers and children. Additionally, research highlights the crucial role caregivers play in helping children build resilience, especially when both have experienced difficult childhoods. Overall, these findings suggest that caregiver-child programs can effectively support children's growth in challenging situations.26789
Who Is on the Research Team?
Neeta Thakur, MD, MPH
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This study is for caregivers over 18 and children aged 2-5 who have faced early life adversity. Caregivers must be the primary caregiver, speak English or Spanish, and have regular internet access. Children with significant medical conditions or caregivers with active suicidality are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive one of three resilience-promoting, caregiver-child interventions: Resilience Clinic, Attachment and Biobehavioral Catch-up, or Resiliency Family Program
Follow-up
Participants are monitored for psychosocial, behavioral, and biological outcomes after intervention
What Are the Treatments Tested in This Trial?
Interventions
- Caregiver-child Intervention
- Enhanced Primary Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Lifelong Medical Care
Collaborator
UCSF Benioff Children's Hospital Oakland
Collaborator
Santa Barbara Neighborhood Clinics
Collaborator
University of California, Santa Barbara
Collaborator
Futures Without Violence
Collaborator